C18 Galactosylceramide-d35 (d18:1/18:0-d35)
C18 Galactosylceramide-d35 (d18:1/18:0-d35) Basic information
- Product Name:
- C18 Galactosylceramide-d35 (d18:1/18:0-d35)
- Synonyms:
-
- C18 Galactosylceramide-d35 (d18:1/18:0-d35)
- N-[(1S,2R,3E)-1-[(β-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecenyl]-octadecanamide-d35
- N-[(1S,2R,3E)-1-[(β-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecenyl]-octadecanamide-d35
- CAS:
- 145176-92-7
- MF:
- C42H46D35NO8
- MW:
- 763.31010223
- Mol File:
- 145176-92-7.mol
C18 Galactosylceramide-d35 (d18:1/18:0-d35) Chemical Properties
- storage temp.
- Store at -20°C
- solubility
- Chloroform: soluble,Chloroform:Methanol (2:1): soluble,Ethanol: heated
- form
- A solid
C18 Galactosylceramide-d35 (d18:1/18:0-d35) Usage And Synthesis
Biological Activity
C18 Galactosylceramide-d35 is intended for use as an internal standard for the quantification of C18 galactosylceramide by GC- or LC-MS. C18 Galactosylceramide is a naturally occurring sphingolipid that has been found in the cerebellum of rats and humans.1,2 It is selectively localized with cholesterol over potassium, sodium, or phosphocholine in rat cerebellum white matter.1 [Matreya, LLC. Catalog No. 1914]
References
1.B?rner, K., Nygren, H., Hagenhoff, B., et al.Distribution of cholesterol and galactosylceramide in rat cerebellar white matterBiochem. Biophys. Acta.1761(3)335-344(2006) 2.Boutin, M., Sun, Y., Shacka, J.J., et al.Tandem mass spectrometry multiplex analysis of glucosylceramide and galactosylceramide isoforms in brain tissues at different stages of Parkinson DiseaseAnal. Chem.88(3)1856-1863(2016)